ExcellGene
With more than 300 completed cell line development projects and over 50 cell lines supporting clinical programs, ExcellGene is a trusted partner for high-performance biologics development. Our proprietary CHO and HEK293 expression platforms deliver exceptional productivity and consistency, enabling rapid progress for bispecifics, multispecifics, and other demanding modalities. From early discovery through clinical development, we provide flexible, end-to-end solutions designed to de-risk timelines and help innovators achieve critical milestones with confidence.
